Home
RADX
RADX News

Latest RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD (RADX) News on July 13, 2025

Radiopharm Theranostics and Cyclotek Sign Clinical Supply Agreement for ¹⁶¹Tb-KLK3-mAb Phase I Clinical Trial in Australia

GlobeNewswire

19 days ago

Radiopharm Theranostics and Cyclotek Sign Clinical Supply Agreement for ¹⁶¹Tb-KLK3-mAb Phase I Clinical Trial in Australia

Radiopharm Theranostics Granted U.S. Food and Drug Administration Fast Track Designation for RAD101 Imaging in Brain Metastases

GlobeNewswire

a month ago

Radiopharm Theranostics Granted U.S. Food and Drug Administration Fast Track Designation for RAD101 Imaging in Brain Metastases

Radiopharm Theranostics Doses First Patient in Phase 1 ‘HEAT’ Trial of 177Lu-RAD202 for Treatment of Advanced HER2-Positive Solid Tumors

GlobeNewswire

a month ago

Radiopharm Theranostics Doses First Patient in Phase 1 ‘HEAT’ Trial of 177Lu-RAD202 for Treatment of Advanced HER2-Positive Solid Tumors

Radiopharm Theranostics Reports Preclinical Lu177-B7H3-mAb Data Demonstrating Favourable Biodistribution and High Tumour Uptake

GlobeNewswire

a month ago

Radiopharm Theranostics Reports Preclinical Lu177-B7H3-mAb Data Demonstrating Favourable Biodistribution and High Tumour Uptake

Independent Non-Executive Director of Radiopharm Theranostics Picks Up 48% More Stock

Simply Wall St.

a month ago

Independent Non-Executive Director of Radiopharm Theranostics Picks Up 48% More Stock

ITM and Radiopharm Sign Supply Agreement for n.c.a. Lutetium-177

GlobeNewswire

2 months ago

ITM and Radiopharm Sign Supply Agreement for n.c.a. Lutetium-177

Radiopharm Theranostics Accelerates 177Lu-RAD204 Phase 1 Dose Escalation Clinical Trial Based on Positive Recommendation from Data Safety and Monitoring Committee (DSMC)

GlobeNewswire

2 months ago

Radiopharm Theranostics Accelerates 177Lu-RAD204 Phase 1 Dose Escalation Clinical Trial Based on Positive Recommendation from Data Safety and Monitoring Committee (DSMC)

RADX: Initiating Coverage – Adding a Radioisotope to Precision Oncology

Zacks Small Cap Research

2 months ago

RADX: Initiating Coverage – Adding a Radioisotope to Precision Oncology

Radiopharm Theranostics to Participate in the D. Boral Capital Inaugural Global Conference

GlobeNewswire

2 months ago

Radiopharm Theranostics to Participate in the D. Boral Capital Inaugural Global Conference

GlobeNewswire

2 months ago

Radiopharm Theranostics Doses First Patient with 18F-RAD101 in U.S. Phase 2b Imaging Study of Brain Metastasis

New RAD202 Data Confirms Positive Tumor Uptake and Favorable Biodistribution

GlobeNewswire

4 months ago

New RAD202 Data Confirms Positive Tumor Uptake and Favorable Biodistribution

Positive Signs As Multiple Insiders Buy Radiopharm Theranostics Stock

Simply Wall St.

5 months ago

Positive Signs As Multiple Insiders Buy Radiopharm Theranostics Stock

New Clinical Trial Data Highlights RAD 101 (18F-Pivalate) Successfully Detects Brain Metastases

GlobeNewswire

5 months ago

New Clinical Trial Data Highlights RAD 101 (18F-Pivalate) Successfully Detects Brain Metastases

Lantheus Increases to 12.16% shareholding in Radiopharm with US$5m (A$8m) Placement

GlobeNewswire

6 months ago

Lantheus Increases to 12.16% shareholding in Radiopharm with US$5m (A$8m) Placement

Radiopharm Announces Strategic Co-Development Partnership with Lantheus for Australia

GlobeNewswire

6 months ago

Radiopharm Announces Strategic Co-Development Partnership with Lantheus for Australia

RAD 202 Receives Approval to Start Phase 1 Therapeutic Trial

GlobeNewswire

7 months ago

RAD 202 Receives Approval to Start Phase 1 Therapeutic Trial

Share on Social Networks: